Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enterprise Value | $82.9M | $161.1M | $57.2M | $90.5M | $54.8M | ($18.7M) | ($5,470.8K) | ($7,313.6K) | $122.0M | $561.4M | $597.7M | $864.4M | $649.8M | $2,013.0M | $750.4M | $1,944.0M | $3,335.5M | $3,035.7M | $3,012.7M | $4,898.8M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Insmed Incorporated's last 12-month Enterprise Value is $11.7B, based on the financial report for Dec 30, 2024 (Q4 2024).
Over the last year, Insmed Incorporated's Enterprise Value growth was 138.2%. The average annual Enterprise Value growth rates for Insmed Incorporated have been 52.9% over the past three years, 43.1% over the past five years.
Over the last year, Insmed Incorporated's Enterprise Value growth was 138.2%, which is higher than industry growth of (0.0%). It indicates that Insmed Incorporated's Enterprise Value growth is Good.